Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CardioMEMS Guided Therapy in Advanced Heart Failure
NCT05284955Phase 4Recruiting
- Start
- Mar 2023
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial (2 arms). Primary endpoint: Kansas City Cardiomyopathy Questionnaire at 6 months. Started Mar 2023; status: recruiting.
Beyond the preview
Go deeper on NCT05284955.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05284955.